{
    "id": "k6bmqrrlmla2dx6vevqlx4tsphugnddj",
    "title": "Full Bayesian Survival Models for Analyzing Human Breast Tumors",
    "info": {
        "author": [
            "Volker Roth, ETH Zurich"
        ],
        "published": "Dec. 20, 2008",
        "recorded": "December 2008",
        "category": [
            "Top->Computer Science->Machine Learning->Bayesian Learning",
            "Top->Computer Science->Bioinformatics"
        ]
    },
    "url": "http://videolectures.net/mlcb08_roth_bsm/",
    "segmentation": [
        [
            "Hello, my name is Fuccaro to thank you for the introduction and thank you for the invitation to this workshop.",
            "So today I'm going to talk about Bayesian survival models for analyzing human breast cancers and so this is joint work with my colleagues from TH with Thomas folks and Joe Bowman.",
            "Suze Orman is a PhD student in my group and Peterbilt and hold them, or are two pathologists from the University Hospital Zurich and Ekedahl is also pathologist from the University Hospital in our hand in Germany."
        ],
        [
            "So let me start with a short overview of this talk, so I'm going to spend, say, two sentences about breast cancer and little bit little bit more sense about this data is tissue microarrays and then I will give a very short introduction to survival models survival regression.",
            "I will introduce a fully Bayesian approach to survival modeling.",
            "I will talk a little bit about feature selection for biomarker detection.",
            "I will introduce.",
            "Mixtures of experts of mixtures of survival experts to analyze this data.",
            "And so I'll close with some results on a novel.",
            "Very interesting breast cancer."
        ],
        [
            "Is it?",
            "So while breast cancer is an interesting object to study, it's still the leading cause of tumor related deaths of women in particular in in Western countries.",
            "So despite the fact that over the last years we have made.",
            "Well, much progress in finding prognostic markers.",
            "This is still an open question.",
            "Or is it still a very interesting problem to find better prognostic markers for this tumor?",
            "So we do that based on data from immunohistochemistry.",
            "So you can do that are based on data on many different data sources, like you can explore arnay data, or you can working on gene sequences.",
            "So we have chosen data from this in your histochemistry pipeline because they are cost effective and more important, they are used on a routine basis in the clinics.",
            "So for those who are not familiar with that is the idea behind using immunohistochemistry is to label proteins based on the principle of antibodies binding specifically to certain antigens and.",
            "So over the last few years.",
            "These tissue microarray technology has been developed as a new method for analyzing these kind of data and these Tmas they have these unique property of allowing a simultaneous incision analysis of up to 1000 primate primary tumor tumors and recent studies have shown that this new technique or this technique in general promises to significantly accelerate studies seeking for biomarkers."
        ],
        [
            "So before I come to any details that would like to put that work into a larger context, so some three years ago we started with building up a what we call a computational pathology pipeline.",
            "DTH and University Hospital in Zurich.",
            "So we saw with tissue samples.",
            "Then these teaching microarrays are produced or they're stained, they are analyzed and scanned with a high resolution scanner.",
            "And of course everything is stored in a huge database.",
            "My colleague Thomas folks primarily works on.",
            "On this low level image analysis, tasks involved in the project, like segmenting the cell nucleus and automatically estimating the staining in the nucleus and in the cytoplasm.",
            "And of course we have a supervision from the medical doctors, so we have a highly high quality data in the and stored in that in that pipeline and the broker I'm going to present here now.",
            "Interacts with the pipeline in the very last stage, so we use this data in order to make to build predictive models for survival."
        ],
        [
            "So yeah, this is the promise slide on teaching micro race.",
            "You see, a breast cancer tissue sample and then very small tissue cylinders of roughly half a millimeter size are punched out with the whole needle, and they are in a paraffin block and very thin slice of roughly half of micro media is sliced from these problems blog, and then the whole slices stained.",
            "So I'm here is here a picture of one of these.",
            "These dots here answer the.",
            "The expression or the color here basically means the expression of a certain biomarker, typically a protein, at a particular part of this issue.",
            "And of course, these these slices are stained with different staining, so you have a simultaneous analysis of the expression of different biomarkers."
        ],
        [
            "So with all these automatic analysis tools and with the manual supervision, we finally created a data matrix, so it's so each row corresponds to a patient in each column presents to estimated expression levels of a protein, and in that data set we had 271 cancer patients and we have observed expression levels of 23 proteins.",
            "So basically we have one large matrix with the yeah with the observed and measured expression values we have.",
            "High level prior knowledge available from previous studies, for example, about the expected originality.",
            "So we expect to see different, distinct different subgroups within samples of that kind.",
            "And based on this data we want to build a survival analysis method which is capable of detecting biomarkers detecting an arbitrary an arbitrary number of subgroups within that sample.",
            "And of course it's capable of modeling uncertainty or the other way round of assigning significance to the."
        ],
        [
            "Adult."
        ],
        [
            "And.",
            "For those of you who are not familiar with survival analysis, I prepared one or two slides on the topic.",
            "So in survival analysis.",
            "So suppose you are given a set of patients and suppose the patient is observed for time T and you have this binary death indicators die, so D = 1 means that these patients died at time T, and now if there's a curd, the likelihood for that event can be decomposed into two factors.",
            "So first of all, the probability of being alive, that is called a survival function.",
            "Times the instantaneous rate of death, which is called the hazard.",
            "And on the other hand, if the patient is still alive at the time point EI, all we know is that a lifetime is larger than than T, and so the likelihood of that event is only the first part.",
            "Here it's only the probability of being alive at the time, so putting everything together for a sample of inpatient, we assume that they are independent.",
            "So we have product of this individual contributions of the likelihoods, and so we have these hazard rates raised to the power of this binary.",
            "That's indicator variables times this survival times.",
            "And here you see some plots of survival functions and.",
            "Typical hazard rates."
        ],
        [
            "OK, so so far we have considered only homogeneous population, so all lifetimes were governed by the same survival function Now, but now we have measurements.",
            "We have covariates, so now we have to find a way of of how these codes can affect the survival and so basically we have two possibilities here.",
            "Either we can they can directly affect the survival and this class of models is called the accelerated life models because basically these covariates they speed up the passage of time basically.",
            "There's a set."
        ],
        [
            "Class of models where these covariates affecting hazard rate and so we have a proportionate increase in risk or decreasing risk due to these.",
            "These measurements here and these are these are called the proportional hazard models.",
            "Of course, both both models seem to be plausable, and so the interesting question."
        ],
        [
            "Is the very both families come inside and so the only known family probability distributions which.",
            "The closing the both assumptions is the Bible distribution and that explains the overwhelming.",
            "The use of these particular distribution in survival analysis and it's also composed of a survival function and the hazard rate of that format.",
            "You see some typical parametric curves for the viable distribution."
        ],
        [
            "OK, so that was in two slides.",
            "Survival analysis.",
            "Now I'm going to focus on the Bayesian version of that."
        ],
        [
            "At.",
            "In the basin version, we start with the likelihood, so this is just a standard Bible likelihood.",
            "the Bible, proportional hazards, likelihood and so we have introduced these variables Eater.",
            "So which is just the product of a measurement of these covariant vectors X and some coefficient vector pedia.",
            "And so first of all, I mean, we all know that typically parametric models are not entirely correct, so we want to allow some stochastic deviations from that model.",
            "And so first of all we modify that, likely by introducing some random variable that allows a stochastic deviation from the underlying model, and so in the in the graphical model we measure this survival times and we have these these observations, the covariance and now we introduce these variables Eater.",
            "And of course, so this feature for these variables we have prior on it and we have hyper priors here and everything together these are graphical model, so the full posterior posterior inference in that model would mean we have evidence here and here.",
            "We have fixed the hyperparameters and we want to jointly estimate the variation of these wide variables here.",
            "And usually that's very complicated.",
            "So what we do is in focus we use the gift sampler and well, it turns out that if you use this model at conditionals are quite simple to sample from because.",
            "For example, the conditional for this regression coefficient coefficient beta here is just a normal distribution because it's normal downstream in normal upstream, so the product is again a normal distribution, antique and play that game for all the other variables."
        ],
        [
            "As well, OK?"
        ],
        [
            "That's that's based on survival models, and now I'm going to talk a little bit on."
        ],
        [
            "On feature selection in these models, so remember that.",
            "In our data set, what we actually measure are quantified quantized intensity levels.",
            "So typically we have data of that country, have categorical variables and what usually does with these variables is to encode that inform of them dummy variables or some orthogonal encoding.",
            "So basically for each protein expression for each, for each protein we have a group of columns in our matrix which corresponds to these.",
            "These columns in the dummy coding.",
            "So for example here we have an example of these four different levels in the quantization scheme, and of course we're not only interested in the proteins themselves, but also in some interactions, and so these guys are the groups in that in that matrix.",
            "And well, I mean classical feature selection would select single columns here, but that probably doesn't really make sense.",
            "You want to select groups of columns, and of course it's quite natural."
        ],
        [
            "To use something like the group lawsuit here, I don't want to go into the details, it's just a combination of a smooth penalty within the groups and the sparseness penalty between the groups."
        ],
        [
            "OK, that's the classic group lawsuit.",
            "And since we want to integrate it in Elevation framework, we interested in a fully Bayesian variant of that.",
            "You can compute that quite quite easily.",
            "You can, it's quite easy to see that a multivariate Laplace prior corresponds with this group lasso penalty, and now we have a problem because the conditions are no longer simple and it's really difficult to sample from.",
            "But you can use a tricky and user hierarchical expansion of the model, introduced some artificial variables.",
            "And again, you finally end up with a model where it's."
        ],
        [
            "It's simple to sample from, for example here for conditional all other variables.",
            "It's quite simple.",
            "Example is this parameters beta because they're still normally distributed so Gibson."
        ],
        [
            "Simple in that model.",
            "So."
        ],
        [
            "So far we're still considered relatively homogeneous populations because all the patients were were model with the same viable shape, so we only considered differences due to this increase in risk associated with with covariant.",
            "So now we want to be a little bit more flexible.",
            "We introduce a mixture component to them, also introduce survival expert.",
            "So we have this additional some here and here.",
            "We have the probability of choosing.",
            "An expert, so an expert is an expert in a certain part of the feature space that makes it a mixture of experts model and each expert has his own viable distribution for explaining the observation associated to this expert."
        ],
        [
            "And so he will see two well known experts, so you can think of that as a as a generative process like hidden Markov model.",
            "You start somewhere and with some probability you choose one of these clusters.",
            "This yeah, this clusters is experts and experts explains the data with some viable distribution and so here we have this mixing proportions and so we have to assign a priority.",
            "It and the country that price.",
            "Additionally distributions can think of it as breaking a stick of length one into several pieces and.",
            "So the problem here is we have to fix the number of experts we want to get rid of that and so we use this well known idea of using a generalized stick breaking process along potentially infinite number of components, which leads to a nonparametric Bayesian infinite mixture model.",
            "And so it's a little bit hard to visualize this in."
        ],
        [
            "Admixture model.",
            "So that was the closest approximation I could find.",
            "So now you have to choose between an infinite number of mixtures of experts and every expert has its own survival model."
        ],
        [
            "How?"
        ],
        [
            "So I would like to conclude with some results on this on the on the on the breast cancer data set.",
            "Maybe before I come to these results, I should say that also in the mixture model, the gift sampling is quite simple, so all the conditions are quite simple to sample from.",
            "So first of all we we we analyzed it.",
            "The clustering part of the model.",
            "So I told you that potentially we can choose an infinite number of mixture of experts of survival experts and here see the.",
            "Color coded the assignment variables.",
            "So here in the burning phase of the Gibbs sampler you see it's locked.",
            "It's fluctuating a lot, but say after 4000 iterations it's it's the model.",
            "Stabili selects two clusters and these two clusters remain constant over the next infinite number of iterations.",
            "So we have a very wide range of different price settings.",
            "We find this stale."
        ],
        [
            "Clusters and then of course we want to analyze what is what is hidden in these two clusters and be used to assume that non programmatic technique for estimating survival times of the patients assigned to these clusters.",
            "And we see that while there is a very nice interpretation of these clusters, one cluster contains all the high risk patients and one cluster contains the low risk patients and it seems to be quite significant this."
        ],
        [
            "Section here.",
            "So coming to the results regarding the biomarker selection, well we found a very interesting result that in the high risk cluster we found a significant 2nd order interaction between three proteins and.",
            "So.",
            "We found the tumor suppressor P 53, which is maybe not so surprising.",
            "We also found this Cape May 2, which is a well known prognostic marker for breast cancer, but we also found was this interaction with these iti H5 protein, and that was recently discovered as a potential new marker, but the really novel insight here is that despite the fact that our model contains or all of single variables and all pairwise interactions.",
            "This three way interaction was much more significant than all the.",
            "The main effect itself, and that that really was interesting because that might lead to the definition of knew prognostic compound markers, so it's really worth looking into high order interactions in problems of that kind."
        ],
        [
            "Coming to conclusions, so will talk at least two sentences about breast cancer.",
            "I've tried to give you a short overview of this data.",
            "The data sources comes from immunohistochemical immuno histo chemistry.",
            "I've tried to give a short overview of this tissue microarray technology.",
            "We have developed patient survival model which is capable of detecting subgroups and potentially infinite number of subgroups.",
            "Um can extract relevant interaction interaction patterns, and since we have access to the full posterior distribution, we can easily access the uncertainty and for the high risk patients we have found this very interesting 3 way interaction which definitely was not known before.",
            "That might lead to the definition of well accepted compound markets in the future."
        ],
        [
            "And I would like to close with a conscience slide.",
            "So on that project introducing the 94 some people from ETH.",
            "University of Basel University Hospital Zurich and University Hospital in our thank you very much for your attention.",
            "So question about the application in breast cancer in breast cancer.",
            "As far as I know, people have identified quite clearly a few clusters of a few categories.",
            "Yeah, so you actually still recover the same classes like let me know Basil yeah, so we can associate our clusters quite nicely with this known clusters.",
            "However, in that data set the distribution was not so not so clear so we have not so many patients or the patients were not equally distributed among these non cluster.",
            "So we had I think from the base type we had only very few samples cluster so it was still.",
            "Interesting to see this clear distinction into a low and high risk patient.",
            "And could you compare your ability?",
            "If you received with more physical waste food preferences, well, yeah, that's a little difficult.",
            "How you would do that.",
            "So basically you would need something like a good test which has been produced under the same conditions and it's very difficult to get that.",
            "What we can say at least is that quite sure that that these interactions very significant, because the model.",
            "Also could have chosen the main effects and but they were not really significant.",
            "So if the this interaction patterns are present, the model never selects a manufact, so at least there we can see we have some comparison with the more traditional approaches, which only usually traditionally focused on the main effects.",
            "And you couldn't use models like that.",
            "Yeah, it's a little bit complicated.",
            "You can.",
            "You could, in principle, Crossville later, likelihood of the prediction, but it's very noisy.",
            "So basically the aero bars of this, like a cross validation, is well, they are very large, so it's quite difficult to have a clear story to make a clear story out of there."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Hello, my name is Fuccaro to thank you for the introduction and thank you for the invitation to this workshop.",
                    "label": 0
                },
                {
                    "sent": "So today I'm going to talk about Bayesian survival models for analyzing human breast cancers and so this is joint work with my colleagues from TH with Thomas folks and Joe Bowman.",
                    "label": 1
                },
                {
                    "sent": "Suze Orman is a PhD student in my group and Peterbilt and hold them, or are two pathologists from the University Hospital Zurich and Ekedahl is also pathologist from the University Hospital in our hand in Germany.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So let me start with a short overview of this talk, so I'm going to spend, say, two sentences about breast cancer and little bit little bit more sense about this data is tissue microarrays and then I will give a very short introduction to survival models survival regression.",
                    "label": 1
                },
                {
                    "sent": "I will introduce a fully Bayesian approach to survival modeling.",
                    "label": 0
                },
                {
                    "sent": "I will talk a little bit about feature selection for biomarker detection.",
                    "label": 0
                },
                {
                    "sent": "I will introduce.",
                    "label": 0
                },
                {
                    "sent": "Mixtures of experts of mixtures of survival experts to analyze this data.",
                    "label": 1
                },
                {
                    "sent": "And so I'll close with some results on a novel.",
                    "label": 0
                },
                {
                    "sent": "Very interesting breast cancer.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Is it?",
                    "label": 0
                },
                {
                    "sent": "So while breast cancer is an interesting object to study, it's still the leading cause of tumor related deaths of women in particular in in Western countries.",
                    "label": 1
                },
                {
                    "sent": "So despite the fact that over the last years we have made.",
                    "label": 0
                },
                {
                    "sent": "Well, much progress in finding prognostic markers.",
                    "label": 0
                },
                {
                    "sent": "This is still an open question.",
                    "label": 0
                },
                {
                    "sent": "Or is it still a very interesting problem to find better prognostic markers for this tumor?",
                    "label": 0
                },
                {
                    "sent": "So we do that based on data from immunohistochemistry.",
                    "label": 0
                },
                {
                    "sent": "So you can do that are based on data on many different data sources, like you can explore arnay data, or you can working on gene sequences.",
                    "label": 1
                },
                {
                    "sent": "So we have chosen data from this in your histochemistry pipeline because they are cost effective and more important, they are used on a routine basis in the clinics.",
                    "label": 0
                },
                {
                    "sent": "So for those who are not familiar with that is the idea behind using immunohistochemistry is to label proteins based on the principle of antibodies binding specifically to certain antigens and.",
                    "label": 0
                },
                {
                    "sent": "So over the last few years.",
                    "label": 0
                },
                {
                    "sent": "These tissue microarray technology has been developed as a new method for analyzing these kind of data and these Tmas they have these unique property of allowing a simultaneous incision analysis of up to 1000 primate primary tumor tumors and recent studies have shown that this new technique or this technique in general promises to significantly accelerate studies seeking for biomarkers.",
                    "label": 1
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So before I come to any details that would like to put that work into a larger context, so some three years ago we started with building up a what we call a computational pathology pipeline.",
                    "label": 1
                },
                {
                    "sent": "DTH and University Hospital in Zurich.",
                    "label": 0
                },
                {
                    "sent": "So we saw with tissue samples.",
                    "label": 0
                },
                {
                    "sent": "Then these teaching microarrays are produced or they're stained, they are analyzed and scanned with a high resolution scanner.",
                    "label": 0
                },
                {
                    "sent": "And of course everything is stored in a huge database.",
                    "label": 0
                },
                {
                    "sent": "My colleague Thomas folks primarily works on.",
                    "label": 0
                },
                {
                    "sent": "On this low level image analysis, tasks involved in the project, like segmenting the cell nucleus and automatically estimating the staining in the nucleus and in the cytoplasm.",
                    "label": 0
                },
                {
                    "sent": "And of course we have a supervision from the medical doctors, so we have a highly high quality data in the and stored in that in that pipeline and the broker I'm going to present here now.",
                    "label": 0
                },
                {
                    "sent": "Interacts with the pipeline in the very last stage, so we use this data in order to make to build predictive models for survival.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So yeah, this is the promise slide on teaching micro race.",
                    "label": 0
                },
                {
                    "sent": "You see, a breast cancer tissue sample and then very small tissue cylinders of roughly half a millimeter size are punched out with the whole needle, and they are in a paraffin block and very thin slice of roughly half of micro media is sliced from these problems blog, and then the whole slices stained.",
                    "label": 1
                },
                {
                    "sent": "So I'm here is here a picture of one of these.",
                    "label": 0
                },
                {
                    "sent": "These dots here answer the.",
                    "label": 0
                },
                {
                    "sent": "The expression or the color here basically means the expression of a certain biomarker, typically a protein, at a particular part of this issue.",
                    "label": 0
                },
                {
                    "sent": "And of course, these these slices are stained with different staining, so you have a simultaneous analysis of the expression of different biomarkers.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So with all these automatic analysis tools and with the manual supervision, we finally created a data matrix, so it's so each row corresponds to a patient in each column presents to estimated expression levels of a protein, and in that data set we had 271 cancer patients and we have observed expression levels of 23 proteins.",
                    "label": 0
                },
                {
                    "sent": "So basically we have one large matrix with the yeah with the observed and measured expression values we have.",
                    "label": 0
                },
                {
                    "sent": "High level prior knowledge available from previous studies, for example, about the expected originality.",
                    "label": 1
                },
                {
                    "sent": "So we expect to see different, distinct different subgroups within samples of that kind.",
                    "label": 0
                },
                {
                    "sent": "And based on this data we want to build a survival analysis method which is capable of detecting biomarkers detecting an arbitrary an arbitrary number of subgroups within that sample.",
                    "label": 1
                },
                {
                    "sent": "And of course it's capable of modeling uncertainty or the other way round of assigning significance to the.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Adult.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And.",
                    "label": 0
                },
                {
                    "sent": "For those of you who are not familiar with survival analysis, I prepared one or two slides on the topic.",
                    "label": 0
                },
                {
                    "sent": "So in survival analysis.",
                    "label": 0
                },
                {
                    "sent": "So suppose you are given a set of patients and suppose the patient is observed for time T and you have this binary death indicators die, so D = 1 means that these patients died at time T, and now if there's a curd, the likelihood for that event can be decomposed into two factors.",
                    "label": 1
                },
                {
                    "sent": "So first of all, the probability of being alive, that is called a survival function.",
                    "label": 1
                },
                {
                    "sent": "Times the instantaneous rate of death, which is called the hazard.",
                    "label": 0
                },
                {
                    "sent": "And on the other hand, if the patient is still alive at the time point EI, all we know is that a lifetime is larger than than T, and so the likelihood of that event is only the first part.",
                    "label": 1
                },
                {
                    "sent": "Here it's only the probability of being alive at the time, so putting everything together for a sample of inpatient, we assume that they are independent.",
                    "label": 1
                },
                {
                    "sent": "So we have product of this individual contributions of the likelihoods, and so we have these hazard rates raised to the power of this binary.",
                    "label": 0
                },
                {
                    "sent": "That's indicator variables times this survival times.",
                    "label": 0
                },
                {
                    "sent": "And here you see some plots of survival functions and.",
                    "label": 0
                },
                {
                    "sent": "Typical hazard rates.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, so so far we have considered only homogeneous population, so all lifetimes were governed by the same survival function Now, but now we have measurements.",
                    "label": 1
                },
                {
                    "sent": "We have covariates, so now we have to find a way of of how these codes can affect the survival and so basically we have two possibilities here.",
                    "label": 0
                },
                {
                    "sent": "Either we can they can directly affect the survival and this class of models is called the accelerated life models because basically these covariates they speed up the passage of time basically.",
                    "label": 0
                },
                {
                    "sent": "There's a set.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Class of models where these covariates affecting hazard rate and so we have a proportionate increase in risk or decreasing risk due to these.",
                    "label": 0
                },
                {
                    "sent": "These measurements here and these are these are called the proportional hazard models.",
                    "label": 1
                },
                {
                    "sent": "Of course, both both models seem to be plausable, and so the interesting question.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is the very both families come inside and so the only known family probability distributions which.",
                    "label": 0
                },
                {
                    "sent": "The closing the both assumptions is the Bible distribution and that explains the overwhelming.",
                    "label": 0
                },
                {
                    "sent": "The use of these particular distribution in survival analysis and it's also composed of a survival function and the hazard rate of that format.",
                    "label": 0
                },
                {
                    "sent": "You see some typical parametric curves for the viable distribution.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "OK, so that was in two slides.",
                    "label": 0
                },
                {
                    "sent": "Survival analysis.",
                    "label": 0
                },
                {
                    "sent": "Now I'm going to focus on the Bayesian version of that.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "At.",
                    "label": 0
                },
                {
                    "sent": "In the basin version, we start with the likelihood, so this is just a standard Bible likelihood.",
                    "label": 0
                },
                {
                    "sent": "the Bible, proportional hazards, likelihood and so we have introduced these variables Eater.",
                    "label": 0
                },
                {
                    "sent": "So which is just the product of a measurement of these covariant vectors X and some coefficient vector pedia.",
                    "label": 0
                },
                {
                    "sent": "And so first of all, I mean, we all know that typically parametric models are not entirely correct, so we want to allow some stochastic deviations from that model.",
                    "label": 0
                },
                {
                    "sent": "And so first of all we modify that, likely by introducing some random variable that allows a stochastic deviation from the underlying model, and so in the in the graphical model we measure this survival times and we have these these observations, the covariance and now we introduce these variables Eater.",
                    "label": 0
                },
                {
                    "sent": "And of course, so this feature for these variables we have prior on it and we have hyper priors here and everything together these are graphical model, so the full posterior posterior inference in that model would mean we have evidence here and here.",
                    "label": 0
                },
                {
                    "sent": "We have fixed the hyperparameters and we want to jointly estimate the variation of these wide variables here.",
                    "label": 0
                },
                {
                    "sent": "And usually that's very complicated.",
                    "label": 0
                },
                {
                    "sent": "So what we do is in focus we use the gift sampler and well, it turns out that if you use this model at conditionals are quite simple to sample from because.",
                    "label": 0
                },
                {
                    "sent": "For example, the conditional for this regression coefficient coefficient beta here is just a normal distribution because it's normal downstream in normal upstream, so the product is again a normal distribution, antique and play that game for all the other variables.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "As well, OK?",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "That's that's based on survival models, and now I'm going to talk a little bit on.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "On feature selection in these models, so remember that.",
                    "label": 1
                },
                {
                    "sent": "In our data set, what we actually measure are quantified quantized intensity levels.",
                    "label": 0
                },
                {
                    "sent": "So typically we have data of that country, have categorical variables and what usually does with these variables is to encode that inform of them dummy variables or some orthogonal encoding.",
                    "label": 0
                },
                {
                    "sent": "So basically for each protein expression for each, for each protein we have a group of columns in our matrix which corresponds to these.",
                    "label": 0
                },
                {
                    "sent": "These columns in the dummy coding.",
                    "label": 1
                },
                {
                    "sent": "So for example here we have an example of these four different levels in the quantization scheme, and of course we're not only interested in the proteins themselves, but also in some interactions, and so these guys are the groups in that in that matrix.",
                    "label": 0
                },
                {
                    "sent": "And well, I mean classical feature selection would select single columns here, but that probably doesn't really make sense.",
                    "label": 1
                },
                {
                    "sent": "You want to select groups of columns, and of course it's quite natural.",
                    "label": 1
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "To use something like the group lawsuit here, I don't want to go into the details, it's just a combination of a smooth penalty within the groups and the sparseness penalty between the groups.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, that's the classic group lawsuit.",
                    "label": 0
                },
                {
                    "sent": "And since we want to integrate it in Elevation framework, we interested in a fully Bayesian variant of that.",
                    "label": 0
                },
                {
                    "sent": "You can compute that quite quite easily.",
                    "label": 0
                },
                {
                    "sent": "You can, it's quite easy to see that a multivariate Laplace prior corresponds with this group lasso penalty, and now we have a problem because the conditions are no longer simple and it's really difficult to sample from.",
                    "label": 1
                },
                {
                    "sent": "But you can use a tricky and user hierarchical expansion of the model, introduced some artificial variables.",
                    "label": 0
                },
                {
                    "sent": "And again, you finally end up with a model where it's.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "It's simple to sample from, for example here for conditional all other variables.",
                    "label": 0
                },
                {
                    "sent": "It's quite simple.",
                    "label": 0
                },
                {
                    "sent": "Example is this parameters beta because they're still normally distributed so Gibson.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Simple in that model.",
                    "label": 0
                },
                {
                    "sent": "So.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So far we're still considered relatively homogeneous populations because all the patients were were model with the same viable shape, so we only considered differences due to this increase in risk associated with with covariant.",
                    "label": 1
                },
                {
                    "sent": "So now we want to be a little bit more flexible.",
                    "label": 0
                },
                {
                    "sent": "We introduce a mixture component to them, also introduce survival expert.",
                    "label": 0
                },
                {
                    "sent": "So we have this additional some here and here.",
                    "label": 0
                },
                {
                    "sent": "We have the probability of choosing.",
                    "label": 0
                },
                {
                    "sent": "An expert, so an expert is an expert in a certain part of the feature space that makes it a mixture of experts model and each expert has his own viable distribution for explaining the observation associated to this expert.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And so he will see two well known experts, so you can think of that as a as a generative process like hidden Markov model.",
                    "label": 0
                },
                {
                    "sent": "You start somewhere and with some probability you choose one of these clusters.",
                    "label": 0
                },
                {
                    "sent": "This yeah, this clusters is experts and experts explains the data with some viable distribution and so here we have this mixing proportions and so we have to assign a priority.",
                    "label": 0
                },
                {
                    "sent": "It and the country that price.",
                    "label": 0
                },
                {
                    "sent": "Additionally distributions can think of it as breaking a stick of length one into several pieces and.",
                    "label": 0
                },
                {
                    "sent": "So the problem here is we have to fix the number of experts we want to get rid of that and so we use this well known idea of using a generalized stick breaking process along potentially infinite number of components, which leads to a nonparametric Bayesian infinite mixture model.",
                    "label": 0
                },
                {
                    "sent": "And so it's a little bit hard to visualize this in.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Admixture model.",
                    "label": 0
                },
                {
                    "sent": "So that was the closest approximation I could find.",
                    "label": 0
                },
                {
                    "sent": "So now you have to choose between an infinite number of mixtures of experts and every expert has its own survival model.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "How?",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So I would like to conclude with some results on this on the on the on the breast cancer data set.",
                    "label": 1
                },
                {
                    "sent": "Maybe before I come to these results, I should say that also in the mixture model, the gift sampling is quite simple, so all the conditions are quite simple to sample from.",
                    "label": 0
                },
                {
                    "sent": "So first of all we we we analyzed it.",
                    "label": 0
                },
                {
                    "sent": "The clustering part of the model.",
                    "label": 0
                },
                {
                    "sent": "So I told you that potentially we can choose an infinite number of mixture of experts of survival experts and here see the.",
                    "label": 0
                },
                {
                    "sent": "Color coded the assignment variables.",
                    "label": 0
                },
                {
                    "sent": "So here in the burning phase of the Gibbs sampler you see it's locked.",
                    "label": 0
                },
                {
                    "sent": "It's fluctuating a lot, but say after 4000 iterations it's it's the model.",
                    "label": 0
                },
                {
                    "sent": "Stabili selects two clusters and these two clusters remain constant over the next infinite number of iterations.",
                    "label": 0
                },
                {
                    "sent": "So we have a very wide range of different price settings.",
                    "label": 1
                },
                {
                    "sent": "We find this stale.",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Clusters and then of course we want to analyze what is what is hidden in these two clusters and be used to assume that non programmatic technique for estimating survival times of the patients assigned to these clusters.",
                    "label": 0
                },
                {
                    "sent": "And we see that while there is a very nice interpretation of these clusters, one cluster contains all the high risk patients and one cluster contains the low risk patients and it seems to be quite significant this.",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Section here.",
                    "label": 0
                },
                {
                    "sent": "So coming to the results regarding the biomarker selection, well we found a very interesting result that in the high risk cluster we found a significant 2nd order interaction between three proteins and.",
                    "label": 0
                },
                {
                    "sent": "So.",
                    "label": 0
                },
                {
                    "sent": "We found the tumor suppressor P 53, which is maybe not so surprising.",
                    "label": 1
                },
                {
                    "sent": "We also found this Cape May 2, which is a well known prognostic marker for breast cancer, but we also found was this interaction with these iti H5 protein, and that was recently discovered as a potential new marker, but the really novel insight here is that despite the fact that our model contains or all of single variables and all pairwise interactions.",
                    "label": 1
                },
                {
                    "sent": "This three way interaction was much more significant than all the.",
                    "label": 0
                },
                {
                    "sent": "The main effect itself, and that that really was interesting because that might lead to the definition of knew prognostic compound markers, so it's really worth looking into high order interactions in problems of that kind.",
                    "label": 1
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Coming to conclusions, so will talk at least two sentences about breast cancer.",
                    "label": 0
                },
                {
                    "sent": "I've tried to give you a short overview of this data.",
                    "label": 0
                },
                {
                    "sent": "The data sources comes from immunohistochemical immuno histo chemistry.",
                    "label": 0
                },
                {
                    "sent": "I've tried to give a short overview of this tissue microarray technology.",
                    "label": 0
                },
                {
                    "sent": "We have developed patient survival model which is capable of detecting subgroups and potentially infinite number of subgroups.",
                    "label": 1
                },
                {
                    "sent": "Um can extract relevant interaction interaction patterns, and since we have access to the full posterior distribution, we can easily access the uncertainty and for the high risk patients we have found this very interesting 3 way interaction which definitely was not known before.",
                    "label": 0
                },
                {
                    "sent": "That might lead to the definition of well accepted compound markets in the future.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And I would like to close with a conscience slide.",
                    "label": 0
                },
                {
                    "sent": "So on that project introducing the 94 some people from ETH.",
                    "label": 0
                },
                {
                    "sent": "University of Basel University Hospital Zurich and University Hospital in our thank you very much for your attention.",
                    "label": 1
                },
                {
                    "sent": "So question about the application in breast cancer in breast cancer.",
                    "label": 0
                },
                {
                    "sent": "As far as I know, people have identified quite clearly a few clusters of a few categories.",
                    "label": 0
                },
                {
                    "sent": "Yeah, so you actually still recover the same classes like let me know Basil yeah, so we can associate our clusters quite nicely with this known clusters.",
                    "label": 0
                },
                {
                    "sent": "However, in that data set the distribution was not so not so clear so we have not so many patients or the patients were not equally distributed among these non cluster.",
                    "label": 0
                },
                {
                    "sent": "So we had I think from the base type we had only very few samples cluster so it was still.",
                    "label": 0
                },
                {
                    "sent": "Interesting to see this clear distinction into a low and high risk patient.",
                    "label": 0
                },
                {
                    "sent": "And could you compare your ability?",
                    "label": 0
                },
                {
                    "sent": "If you received with more physical waste food preferences, well, yeah, that's a little difficult.",
                    "label": 0
                },
                {
                    "sent": "How you would do that.",
                    "label": 0
                },
                {
                    "sent": "So basically you would need something like a good test which has been produced under the same conditions and it's very difficult to get that.",
                    "label": 0
                },
                {
                    "sent": "What we can say at least is that quite sure that that these interactions very significant, because the model.",
                    "label": 0
                },
                {
                    "sent": "Also could have chosen the main effects and but they were not really significant.",
                    "label": 0
                },
                {
                    "sent": "So if the this interaction patterns are present, the model never selects a manufact, so at least there we can see we have some comparison with the more traditional approaches, which only usually traditionally focused on the main effects.",
                    "label": 0
                },
                {
                    "sent": "And you couldn't use models like that.",
                    "label": 0
                },
                {
                    "sent": "Yeah, it's a little bit complicated.",
                    "label": 0
                },
                {
                    "sent": "You can.",
                    "label": 0
                },
                {
                    "sent": "You could, in principle, Crossville later, likelihood of the prediction, but it's very noisy.",
                    "label": 0
                },
                {
                    "sent": "So basically the aero bars of this, like a cross validation, is well, they are very large, so it's quite difficult to have a clear story to make a clear story out of there.",
                    "label": 0
                }
            ]
        }
    }
}